Mycophenolic acid
Sold as Myfortic, Micassyl ec, Deprol, Lesor, Transwell
(E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid
Drag to rotate. Structure from PubChem CID 446541.
Background
Registration
- Applicants
- 3
- Registrations
- 10
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Novartis South Africa (Pty) Ltd | Myfortic | 180 mg / 360 mg | 370158, 370159 | S4 | PIPIL |
| Accord Healthcare (Pty) LtdCancelled | Micassyl ec | 180, 360 | 471207, 471208 | S4 | None |
| Ascend Laboratories (Pty) Ltd | Deprol, Lesor, Transwell | 180, 360 | 530386, 530387, 530388.386, 530389.387, 530390.386, 530391.387 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Myfortic 180 EACH TABLET CONTAINS MYCOPHENOLIC ACID 180,0 mg | 180 mg / 360 mgTablets | 37015837/34/0158Approved 17 January 2025 | Registered | S4 | PIPIL |
| Myfortic 360 EACH TABLET CONTAINS MYCOPHENOLIC ACID 360,0 mg | 180 mg / 360 mgTablets | 37015937/34/0159Approved 17 January 2025 | Registered | S4 | PIPIL |
| Micassyl ec 180 Each Tablet contains: Mycophenolic Acid 180,0 mg | 180 | 47120747/32.2/1207 | Cancelled | S4 | None |
| Micassyl ec 360 Each Tablet contains: Mycophenolic Acid | 360 | 47120847/32.2/1208 | Cancelled | S4 | None |
| Deprol 180 EACH TABLET CONTAINS MYCOPHENOLATE SODIUM EQUIVALENT TO MYCOPHENOLIC ACID 180,0 mg | 180 | 53038653/32.2/0386 | Registered | S4 | None |
| Deprol 360 EACH TABLET CONTAINS MYCOPHENOLATE SODIUM EQUIVALENT TO MYCOPHENOLIC ACID 180,0 mg | 360 | 53038753/32.2/0387 | Registered | S4 | None |
| Lesor 180 EACH TABLET CONTAINS MYCOPHENOLATE SODIUM EQUIVALENT TO MYCOPHENOLIC ACID 180,0 mg | 180 | 530388.38653/32.2/0388.386 | Registered | S4 | None |
| Lesor 360 EACH TABLET CONTAINS MYCOPHENOLATE SODIUM EQUIVALENT TO MYCOPHENOLIC ACID 360,0 mg | 360 | 530389.38753/32.2/0389.387 | Registered | S4 | None |
| Transwell 180 EACH TABLET CONTAINS MYCOPHENOLATE SODIUM EQUIVALENT TO MYCOPHENOLIC ACID 180,0 mg | 180 | 530390.38653/32.2/0390.386 | Registered | S4 | None |
| Transwell 360 EACH TABLET CONTAINS MYCOPHENOLATE SODIUM EQUIVALENT TO MYCOPHENOLIC ACID 360,0 mg | 360 | 530391.38753/32.2/0391.387 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Mycophenolic acid
S4: Mycophenolic acid
Consolidated Schedules 06 July 2026, line 7195
Pharmacological class: Complementary Medicines: Health Supplements (class 34)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.